tiprankstipranks
Trending News
More News >
Bio-Rad Laboratories (BIO)
NYSE:BIO
US Market

Bio-Rad Laboratories (BIO) Ratios

Compare
889 Followers

Bio-Rad Laboratories Ratios

BIO's free cash flow for Q1 2025 was $0.52. For the 2025 fiscal year, BIO's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.55 5.83 5.55 2.92 3.39
Quick Ratio
4.29 4.34 4.29 2.08 2.40
Cash Ratio
0.76 0.77 0.76 0.69 1.05
Solvency Ratio
-0.89 -0.14 -0.89 1.08 1.29
Operating Cash Flow Ratio
0.34 0.72 0.34 0.96 0.91
Short-Term Operating Cash Flow Coverage
418.17 771.49 418.17 1.34K 442.56
Net Current Asset Value
$ -728.44M$ -509.61M$ -728.44M$ -2.12B$ -952.84M
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.11 0.09 <0.01 <0.01
Debt-to-Equity Ratio
0.12 0.16 0.12 <0.01 <0.01
Debt-to-Capital Ratio
0.11 0.14 0.11 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.11 0.12 0.11 <0.01 <0.01
Financial Leverage Ratio
1.40 1.41 1.40 1.30 1.31
Debt Service Coverage Ratio
-88.45 -7.92 -88.45 2.17K 172.85
Interest Coverage Ratio
12.66 6.83 12.66 315.56 18.80
Debt to Market Cap
0.10 0.13 0.10 <0.01 <0.01
Interest Debt Per Share
41.51 49.81 41.51 0.42 1.21
Net Debt to EBITDA
-0.17 -1.65 -0.17 -0.08 -0.13
Profitability Margins
Gross Profit Margin
55.93%53.42%55.93%56.14%56.48%
EBIT Margin
-166.51%-29.97%-166.51%186.50%193.65%
EBITDA Margin
-160.19%-22.77%-160.19%192.55%200.53%
Operating Profit Margin
17.22%12.65%17.22%16.75%16.14%
Pretax Profit Margin
-167.87%-31.82%-167.87%186.08%192.79%
Net Profit Margin
-129.45%-23.86%-129.45%145.57%149.83%
Continuous Operations Profit Margin
-129.45%-23.86%-129.45%145.57%149.52%
Net Income Per EBT
77.11%74.97%77.11%78.23%77.72%
EBT Per EBIT
-974.74%-251.66%-974.74%1111.12%1194.20%
Return on Assets (ROA)
-26.87%-5.18%-26.87%23.93%29.40%
Return on Equity (ROE)
-37.73%-7.29%-37.73%31.13%38.61%
Return on Capital Employed (ROCE)
3.73%2.87%3.73%2.86%3.33%
Return on Invested Capital (ROIC)
2.87%2.14%2.87%2.23%2.57%
Return on Tangible Assets
-28.42%-5.51%-28.42%24.77%30.56%
Earnings Yield
-28.96%-6.76%-28.96%18.87%21.98%
Efficiency Ratios
Receivables Turnover
5.67 5.46 5.67 6.90 6.07
Payables Turnover
9.14 8.60 9.14 9.03 7.94
Inventory Turnover
1.72 1.59 1.72 2.24 1.78
Fixed Asset Turnover
4.12 3.69 4.12 4.20 3.67
Asset Turnover
0.21 0.22 0.21 0.16 0.20
Working Capital Turnover Ratio
1.44 1.04 1.44 2.08 1.83
Cash Conversion Cycle
237.12 253.35 237.12 175.42 219.21
Days of Sales Outstanding
64.43 66.82 64.43 52.90 60.14
Days of Inventory Outstanding
212.61 228.95 212.61 162.94 205.02
Days of Payables Outstanding
39.91 42.42 39.91 40.42 45.95
Operating Cycle
277.03 295.77 277.03 215.83 265.16
Cash Flow Ratios
Operating Cash Flow Per Share
6.53 12.84 6.53 22.01 19.33
Free Cash Flow Per Share
2.70 7.47 2.70 17.96 16.00
CapEx Per Share
3.83 5.36 3.83 4.05 3.32
Free Cash Flow to Operating Cash Flow
0.41 0.58 0.41 0.82 0.83
Dividend Paid and CapEx Coverage Ratio
1.70 2.39 1.70 5.43 5.82
Capital Expenditure Coverage Ratio
1.70 2.39 1.70 5.43 5.82
Operating Cash Flow Coverage Ratio
0.16 0.27 0.16 59.67 40.93
Operating Cash Flow to Sales Ratio
0.07 0.14 0.07 0.22 0.23
Free Cash Flow Yield
0.64%2.31%0.64%2.38%2.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-3.45 -14.80 -3.45 5.30 4.55
Price-to-Sales (P/S) Ratio
4.47 3.53 4.47 7.71 6.82
Price-to-Book (P/B) Ratio
1.30 1.08 1.30 1.65 1.76
Price-to-Free Cash Flow (P/FCF) Ratio
155.99 43.21 155.99 42.07 36.42
Price-to-Operating Cash Flow Ratio
64.41 25.15 64.41 34.33 30.16
Price-to-Earnings Growth (PEG) Ratio
0.02 0.18 0.02 0.46 0.04
Price-to-Fair Value
1.30 1.08 1.30 1.65 1.76
Enterprise Value Multiple
-2.96 -17.15 -2.96 3.92 3.27
Enterprise Value
13.29B 10.43B 13.29B 22.08B 16.70B
EV to EBITDA
-2.96 -17.15 -2.96 3.92 3.27
EV to Sales
4.74 3.91 4.74 7.55 6.56
EV to Free Cash Flow
165.50 47.80 165.50 41.22 35.06
EV to Operating Cash Flow
68.34 27.83 68.34 33.63 29.04
Tangible Book Value Per Share
298.02 274.13 298.02 438.00 315.39
Shareholders’ Equity Per Share
322.82 299.26 322.82 458.15 331.90
Tax and Other Ratios
Effective Tax Rate
0.23 0.25 0.23 0.22 0.22
Revenue Per Share
94.08 91.45 94.08 97.97 85.52
Net Income Per Share
-121.79 -21.82 -121.79 142.61 128.13
Tax Burden
0.77 0.75 0.77 0.78 0.78
Interest Burden
1.01 1.06 1.01 1.00 1.00
Research & Development to Revenue
0.09 0.09 0.09 0.09 0.09
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.02 0.02
Income Quality
-0.05 -0.59 -0.05 0.15 0.15
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis